Who is sponsoring NCT02961322?

NCT02961322 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT02961322?

Interventions in NCT02961322: lobo-isthmectomy assisted robot.

What condition does NCT02961322 study?

NCT02961322 studies Lobo-isthmectomy.

Is NCT02961322 still recruiting?

NCT02961322 is currently terminated. Last updated 6 May 2023.

Last reviewed 2023-05-06 · How we verify

NCT02961322: LIRA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medico-economic Study of the Lobo-isthmectomy Assisted Robot

Terminated NA Last updated 6 May 2023

What this trial tests

NA trial testing lobo-isthmectomy assisted robot in Lobo-isthmectomy in 9 participants. Terminated before completion.

Timeline

30 November 2016

Primary endpoint
10 November 2019

10 November 2019

Quick facts

Lead sponsor	University Hospital, Montpellier
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	9
Start date	30 November 2016
Primary completion	10 November 2019
Estimated completion	10 November 2019

Drugs / interventions tested

lobo-isthmectomy assisted robot

Conditions studied

Lobo-isthmectomy — all drugs for Lobo-isthmectomy →

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 90, any sex, with Lobo-isthmectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study of health economics longitudinal cohort on the evaluation of direct medical cost of a surgical technique based on the use of an innovative device (the da Vinci® surgical robot Si) and its comprehensive care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02961322 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 6 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02961322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing